HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tasquinimod

a lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer; structure in first source
Also Known As:
4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-((4-trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide; ABR-215050
Networked: 27 relevant articles (4 outcomes, 15 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Isaacs, John T: 8 articles (09/2014 - 12/2006)
2. Leanderson, Tomas: 7 articles (02/2015 - 12/2006)
3. Olsson, Anders: 7 articles (02/2015 - 12/2006)
4. Pili, Roberto: 6 articles (02/2015 - 12/2006)
5. Dalrymple, Susan L: 5 articles (09/2014 - 12/2006)
6. Björk, Anders: 4 articles (02/2013 - 12/2006)
7. Carducci, Michael A: 3 articles (11/2014 - 10/2011)
8. Shen, Li: 2 articles (02/2015 - 01/2014)
9. Sundstedt, Anette: 2 articles (02/2015 - 01/2015)
10. Törngren, Marie: 2 articles (01/2015 - 06/2012)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Vascular Tissue Neoplasms
5. Disease Progression

Related Drugs and Biologics

1. quinoline-3-carboxamide
2. taxane
3. Cytochrome P-450 CYP3A
4. Ketoconazole (Nizoral)
5. Cytochromes
6. docetaxel (Taxotere)
7. ipilimumab
8. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
9. tasquinimod
10. sipuleucel-T (APC8015)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Castration
4. Immunomodulation
5. Immunotherapy